Lemonaid Health vs Willow: Which GLP-1 Provider Is Better?
Willow beats Lemonaid Health overall, scoring 7.5/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Lemonaid Health is published $129/mo; total not verified; Willow is from $299/mo. Choose Lemonaid Health for users who want a flexible membership with broad medication o. Choose Willow for users who want comprehensive clinical support with flexibili.
A side-by-side look at Lemonaid Health and Willow to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Lemonaid Health
#37 of 54Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).
Visit Lemonaid HealthWillow
#20 of 54Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.
Visit Willow| Feature | Lemonaid Health | Willow |
|---|---|---|
| Why each one | One of the oldest and most established telehealth brands in the GLP-1 space, over a decade of operation and physician-only prescribing standards that exceed most competitors. | One of the few compounded-only platforms offering both injectable and daily oral semaglutide tablets, useful for users who want a non-injectable option without leaving the GLP-1 compounded category. |
| Our Score | 7.2/10 | 7.5/10 |
| Headline Price | published $129/mo; total not verified | from $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a flexible membership with broad medication options, $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449) | Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes |
| Watch out for | Membership and medication billed separately, the $49/mo number is just the membership, not all-in | Compounded-only, no brand-name Wegovy or Zepbound through the platform |
| Ranking | #37 | #20 |
| Get started | Visit Lemonaid Health | Visit Willow |
Pros & Cons Compared
Lemonaid Health
Pros
- +2026 restructure, $49/mo Weight Loss Membership (replaces the old $25/visit model)
- +6-month plan discount, compounded tirzepatide drops to $229/mo on a 6-month commitment
- +Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
- +Established since 2013 with physician-only prescribing and rigorous intake
Cons
- −Membership and medication billed separately, the $49/mo number is just the membership, not all-in
- −Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high, read as access, not value
- −Best compounded pricing requires a 6-month commitment
- −The 23andMe acquisition created some uncertainty about the platform's long-term focus
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
- +$299/mo all-in for compounded semaglutide with monthly provider support
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Compounded-only, no brand-name Wegovy or Zepbound through the platform
- −Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
- −Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024, less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out Lemonaid Health with a score of 7.5/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Lemonaid Health is published $129/mo; total not verified; Willow is from $299/mo. Lemonaid Health offers both brand-name and compounded medications, giving you more flexibility. Choose Lemonaid Health if you want: users who want a flexible membership with broad medication options, $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449). Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.
Read Full Reviews
Related comparisons
Other matchups readers comparing Lemonaid Health or Willow tend to look at next.
- Lemonaid Health vs Foundpublished $129/mo; total not verified
- Lemonaid Health vs Oak Longevityfrom $119/mo
- Lemonaid Health vs Ivim Healthfrom $150/mo
- Willow vs Direct Meds GLP-1from $297/mo
- Willow vs MyStart Healthfrom $299/mo
- Willow vs SnagRxpublished $69/mo; total not verified
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Willow · 7.5/10